嗜癖治療薬の世界市場レポート 2025年

嗜癖治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.5％で96億2,000万米ドルに成長します。予測期間の成長は、薬物意識向上キャンペーンの高まり、合成麻薬や新しい精神活性物質の出現、ライフスタイルやストレス要因の変化、リハビリ施設の拡大、依存症治療における遠隔医療サービスの統合などに起因すると考えられます。予測期間における主な動向には、診断における技術的進歩、神経科学的進歩、依存症問題に対処するための製薬会社とその他の利害関係者との提携や協力、嗜癖治療薬.I.C.向けの革新的な薬剤の発売などが含まれます。

予測されるアルコール消費の増加は、依存症治療薬市場の成長を促進する重要な要因です。アルコール消費は、エチルアルコールを含む飲料の摂取を意味し、依存症治療薬は、その抑うつ作用を緩和し、神経伝達物質間のバランスを回復させることによって、アルコール関連依存症に対処することを目的としています。これらの治療薬は、アルコールへの欲求を抑え、不眠、不安、落ち着きのなさなどの禁断症状を緩和し、アルコール消費の減少を促します。注目すべきは、2023年2月にカナダ統計局が発表した報告書によると、小売店や酒類販売当局におけるアルコール飲料の売上高が顕著に急増し、2022年3月期には261億米ドルに達し、前年比2.4％増となったことです。ワインも2.1％増の81億米ドルに達しました。2021-2022年のアルコール販売額全体に占めるビールの割合は34.9%、次いでワイン31.3%、スピリッツ25.8%、シードル・クーラー8.0%となっています。その結果、アルコール消費量の増加が中毒治療薬の需要に拍車をかけています。

世界的に急増しているヘルスケア支出は、中毒治療薬市場の拡大を促進すると考えられています。ヘルスケア支出には、特定の期間にヘルスケア関連の商品やサービスに向けられる財源が含まれ、中毒治療薬の成長に大きく寄与しています。ヘルスケア支出の増加は、治療アクセスの改善を促進し、研究開発イニシアチブを支援し、革新的な治療法の採用を促進し、薬物使用障害に対する包括的なヘルスケアサービスを強化します。2022年3月にメディケア＆メディケイド・サービスセンターが発表した2021-2030年国民医療費（NHE）報告書に示されているように、予測成長率は、2021年から2030年にかけて国民医療費が年平均5.1％増加し、約6兆8,000億米ドルに達することを示しています。特に、メディケアの支出は年率7.2％増加し、メディケイドの支出は2021年から2030年にかけて年率5.6％増加すると予想されています。このヘルスケア支出の急増は、中毒治療薬市場の拡大を推進する原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界嗜癖治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の嗜癖治療薬市場：成長率分析
• 世界の嗜癖治療薬市場の実績：規模と成長, 2019-2024
• 世界の嗜癖治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界嗜癖治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の嗜癖治療薬市場薬の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブプレノルフィン
• ナルトレキソン
• ブプロピオン
• ジスルフィラム
• ニコチン代替製品
• バレニクリン
• その他の薬物
• 世界の嗜癖治療薬市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オピオイド中毒治療
• アルコール依存症治療
• ニコチン中毒治療
• その他の薬物依存症治療
• 世界の嗜癖治療薬市場治療センター別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 入院治療センター
• 住宅治療センター
• 外来治療センター
• 世界の嗜癖治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 医療用品店
• その他の流通チャネル
• 世界の嗜癖治療薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 公共
• プライベート
• 政府
• 世界の嗜癖治療薬市場、ブプレノルフィンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• サブテックス
• サブオキソン
• 世界の嗜癖治療薬市場ナルトレキソンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口ナルトレキソン
• 徐放性ナルトレキソン（ビビトロール）
• 世界の嗜癖治療薬市場、ブプロピオンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウェルブトリン
• ザイバン
• 世界の嗜癖治療薬市場、ジスルフィラムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アンタビューズ
• 世界の嗜癖治療薬市場ニコチン代替製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ニコチンパッチ
• ニコチンガム
• ニコチン吸入器
• ニコチントローチ
• 世界の嗜癖治療薬市場、バレニクリンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• チャンピックス（チャンピックス）
• 世界の嗜癖治療薬市場、その他の医薬品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アカンプロサート
• トピラマート
• ガバペンチン

第7章 地域別・国別分析

• 世界の嗜癖治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の嗜癖治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 嗜癖治療薬市場：競合情勢
• 嗜癖治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sun Pharmaceutical Industries Limited
• Perrigo Company plc
• Purdue Pharma L.P.
• Dr. Reddy's Laboratories Ltd.
• Cipla Inc.
• Hikma Pharmaceuticals plc
• Amneal Pharmaceuticals Inc.
• Mallinckrodt Plc
• Alkermes plc.
• Glenmark Pharmaceuticals Limited
• Indivior plc.
• Lannett Company Inc.
• BioDelivery Sciences International Inc.
• Insys Therapeutics Inc.
• Camurus AB

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 嗜癖治療薬市場2029：新たな機会を提供する国
• 嗜癖治療薬市場2029：新たな機会を提供するセグメント
• 嗜癖治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Addiction therapeutics encompasses the medications, treatments, and management strategies designed to address various forms of addiction, assisting individuals in overcoming substance use disorders (SUDs) and other addictive behaviors. The approach involves a combination of medications and therapeutic interventions, including group and individual therapy sessions, aimed at preventing substance misuse and supporting recovery.

Key addiction therapeutics include medications such as buprenorphine, naltrexone, bupropion, disulfiram, nicotine replacement products, varenicline, and others. For instance, buprenorphine is a semi-synthetic narcotic analgesic used to mimic the effects of opioid medicines, helping to prevent withdrawal symptoms when an individual discontinues opioid use. Different types of addiction therapeutics cater to specific substance dependencies, including opioid addiction treatment, alcohol addiction treatment, nicotine addiction treatment, and treatments for other substance addictions. These therapeutic interventions can be implemented in various treatment centers, including inpatient treatment centers, residential treatment centers, and outpatient treatment centers. Distribution channels for addiction therapeutics encompass hospital pharmacies, medical stores, and others. These therapeutic solutions are accessible through public, private, and government healthcare settings, contributing to comprehensive and widespread addiction treatment and recovery efforts.

The addictions therapeutics market research report is one of a series of new reports from The Business Research Company that provides addictions therapeutics market statistics, including addictions therapeutics industry global market size, regional shares, competitors with a addictions therapeutics market share, detailed addictions therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the addictions therapeutics industry. This addictions therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The addictions therapeutics market size has grown strongly in recent years. It will grow from $7.05 billion in 2024 to $7.48 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increased use of addictive substances such as alcohol, tobacco, and drugs, rising awareness and escalating prevalence of substance abuse disorders, legalization of marijuana in various states, increased funding and support for addiction treatment initiatives

The addictions therapeutics market size is expected to see strong growth in the next few years. It will grow to $9.62 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rising drug awareness campaigns, emergence of synthetic drugs and new psychoactive substances, changing lifestyles and stress factors, expanding rehabilitation facilities, integration of telehealth services in addiction treatment. Major trends in the forecast period include technological advancements in diagnostics, neuroscientific advances, partnerships and collaborations between pharmaceutical companies and other stakeholders to address addiction issues, innovative drug launch for addictions therapeutics.

The projected rise in alcohol consumption stands as a significant driver propelling the growth of the addiction therapeutics market. Alcohol consumption entails the intake of beverages containing ethyl alcohol, and addiction therapeutics aim to address alcohol-related addiction by moderating its depressive effects and reinstating the balance between neurotransmitters. These therapeutics help reduce alcohol cravings, alleviate withdrawal symptoms such as insomnia, anxiety, and restlessness, thereby encouraging reduced alcohol consumption. Notably, a report by Statistics Canada in February 2023 revealed a noteworthy surge in alcoholic beverage sales at retail outlets and liquor authorities, reaching $26.1 billion for the fiscal year ending March 31, 2022-an increase of 2.4% from the previous year. Wine sales also experienced a 2.1% uptick, reaching $8.1 billion in the same period. Beer constituted 34.9% of total alcohol sales value in 2021-2022, followed by wine at 31.3%, spirits at 25.8%, and ciders and coolers at 8.0%. Consequently, the escalating alcohol consumption is fueling the demand for addiction therapeutics.

The burgeoning healthcare expenditure globally is poised to foster the expansion of the addiction therapeutics market. Healthcare expenditure encompasses the financial resources directed towards healthcare-related goods and services over a specific period, contributing significantly to the growth of addiction therapeutics. Increased healthcare expenditure facilitates improved treatment accessibility, supports research and development initiatives, promotes the adoption of innovative therapies, and enhances comprehensive healthcare services for substance use disorders. As illustrated by the 2021-2030 National Health Expenditure (NHE) report from the Centers for Medicare & Medicaid Services in March 2022, the projected growth indicates an average annual increase of 5.1% in national health spending between 2021 and 2030, culminating in nearly $6.8 trillion. Notably, Medicare spending is expected to rise by 7.2% annually, while Medicaid spending will grow at a 5.6% annual rate from 2021 to 2030. This upsurge in healthcare expenditure serves as a driving force propelling the expansion of the addiction therapeutics market.

Prominent players within the addiction therapeutics market are actively pioneering innovative solutions, particularly drugs aimed at addressing cocaine use disorders (CUD), to cater to broader customer bases, amplify sales, and augment revenue streams. Drugs developed for CUD are specifically crafted medications intended to assist individuals grappling with cocaine addiction or dependence. An exemplar in this domain unfolded in January 2023 when Tempero Bio, a US-based biopharmaceutical firm, revealed the FDA's approval for TMP-301, its investigational candidate. This distinct product distinguishes itself as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM), uniquely tailored to combat CUD. TMP-301's standout characteristics lie in its potency, selectivity, and oral availability, aimed at effectively curbing the hyperactive glutamate signaling associated with CUD.

Key industry players within the addiction therapeutics sector are strategically embracing partnerships to tackle nicotine addiction through smartphone interventions. Strategic partnerships denote collaborative endeavors wherein companies synergize their strengths and resources for mutual advantages and success. For instance, in January 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology giant, entered into a partnership with Alex Therapeutics, a Sweden-based entity specializing in digital therapeutics. The primary focus of this collaboration revolves around a digital therapeutic designed to combat nicotine addiction via smartphone intervention. Developed by Alex Therapeutics in alignment with the specifications of the German healthcare system alongside Pfizer Germany, the medical device represents the crux of this partnership. Leveraging Alex Therapeutics' AI-powered digital therapeutics platform, the Alex DTx Platform, this collaboration integrates evidence-based psychological approaches, notably Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT), with artificial intelligence. The platform offers personalized standalone treatments, aiming to address unmet needs among patients on a global scale. This strategic alliance signifies a concerted effort to revolutionize addiction therapeutics using digital interventions, potentially reshaping nicotine addiction treatments.

In March 2023, Indivior, a US-based pharmaceutical company, completed the acquisition of Opiant Pharmaceuticals Inc for an estimated $145 million. This strategic move is intended to enhance Indivior's portfolio in investigational opioid overdose therapy, fortify its scientific research capabilities, and further expand its offerings in the field of addiction treatment. Opiant Pharmaceuticals Inc., a US-based biopharmaceutical company specializing in medicines for addiction and drug overdose.

Major companies operating in the addictions therapeutics market include Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

North America was the largest region in the addictions therapeutics market in 2024. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the addictions therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The addiction therapeutics market consists of revenues earned by entities by providing cognitive behavioral therapy, contingency management for addiction, rational emotive behavior therapy (REBT), motivational interviewing, family therapy for addiction, facilitation therapy for addiction, eye movement desensitization and reprocessing (EMDR), dialectical behavior therapy, matrix model for addiction and person-centered therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The addiction therapeutics market also includes sales of suboxone, methadone, naltrexone, antidepressants, and acamprosate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Addictions Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on addictions therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for addictions therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The addictions therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Buprenorphine; Naltrexone; Bupropion; Disulfiram; Nicotine Replacement Products; Varenicline; Other Drugs
• 2) By Treatment Type: Opioid Addiction Treatment; Alcohol Addiction Treatment; Nicotine Addiction Treatment; Other Substance Addiction Treatment
• 3) By Treatment Center: Inpatient Treatment Center; Residential Treatment Center; Outpatient Treatment Center
• 4) By Distribution Channel: Hospital Pharmacies; Medical Stores; Other Distribution Channel
• 5) By Application: Public; Private; Government
• Subsegments:
• 1) By Buprenorphine: Subutex; Suboxone
• 2) By Naltrexone: Oral Naltrexone; Extended-Release Naltrexone (Vivitrol)
• 3) By Bupropion: Wellbutrin; Zyban
• 4) By Disulfiram: Antabuse
• 5) By Nicotine Replacement Products: Nicotine Patches; Nicotine Gum; Nicotine Inhalers; Nicotine Lozenges
• 6) By Varenicline: Chantix (Champix)
• 7) By Other Drugs: Acamprosate; Topiramate; Gabapentin
• Companies Mentioned: Pfizer Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Bausch Health Companies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Addictions Therapeutics Market Characteristics

3. Addictions Therapeutics Market Trends And Strategies

4. Addictions Therapeutics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Addictions Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Addictions Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Addictions Therapeutics Market Growth Rate Analysis
• 5.4. Global Addictions Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Addictions Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Addictions Therapeutics Total Addressable Market (TAM)

6. Addictions Therapeutics Market Segmentation

• 6.1. Global Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buprenorphine
• Naltrexone
• Bupropion
• Disulfiram
• Nicotine Replacement Products
• Varenicline
• Other Drugs
• 6.2. Global Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Opioid Addiction Treatment
• Alcohol Addiction Treatment
• Nicotine Addiction Treatment
• Other Substance Addiction Treatment
• 6.3. Global Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inpatient Treatment Center
• Residential Treatment Center
• Outpatient Treatment Center
• 6.4. Global Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Medical Stores
• Other Distribution Channel
• 6.5. Global Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Public
• Private
• Government
• 6.6. Global Addictions Therapeutics Market, Sub-Segmentation Of Buprenorphine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subutex
• Suboxone
• 6.7. Global Addictions Therapeutics Market, Sub-Segmentation Of Naltrexone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Naltrexone
• Extended-Release Naltrexone (Vivitrol)
• 6.8. Global Addictions Therapeutics Market, Sub-Segmentation Of Bupropion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wellbutrin
• Zyban
• 6.9. Global Addictions Therapeutics Market, Sub-Segmentation Of Disulfiram, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antabuse
• 6.10. Global Addictions Therapeutics Market, Sub-Segmentation Of Nicotine Replacement Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nicotine Patches
• Nicotine Gum
• Nicotine Inhalers
• Nicotine Lozenges
• 6.11. Global Addictions Therapeutics Market, Sub-Segmentation Of Varenicline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chantix (Champix)
• 6.12. Global Addictions Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acamprosate
• Topiramate
• Gabapentin

7. Addictions Therapeutics Market Regional And Country Analysis

• 7.1. Global Addictions Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Addictions Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Addictions Therapeutics Market

• 8.1. Asia-Pacific Addictions Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Addictions Therapeutics Market

• 9.1. China Addictions Therapeutics Market Overview
• 9.2. China Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Addictions Therapeutics Market

• 10.1. India Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Addictions Therapeutics Market

• 11.1. Japan Addictions Therapeutics Market Overview
• 11.2. Japan Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Addictions Therapeutics Market

• 12.1. Australia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Addictions Therapeutics Market

• 13.1. Indonesia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Addictions Therapeutics Market

• 14.1. South Korea Addictions Therapeutics Market Overview
• 14.2. South Korea Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Addictions Therapeutics Market

• 15.1. Western Europe Addictions Therapeutics Market Overview
• 15.2. Western Europe Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Addictions Therapeutics Market

• 16.1. UK Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Addictions Therapeutics Market

• 17.1. Germany Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Addictions Therapeutics Market

• 18.1. France Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Addictions Therapeutics Market

• 19.1. Italy Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Addictions Therapeutics Market

• 20.1. Spain Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Addictions Therapeutics Market

• 21.1. Eastern Europe Addictions Therapeutics Market Overview
• 21.2. Eastern Europe Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Addictions Therapeutics Market

• 22.1. Russia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Addictions Therapeutics Market

• 23.1. North America Addictions Therapeutics Market Overview
• 23.2. North America Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Addictions Therapeutics Market

• 24.1. USA Addictions Therapeutics Market Overview
• 24.2. USA Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Addictions Therapeutics Market

• 25.1. Canada Addictions Therapeutics Market Overview
• 25.2. Canada Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Addictions Therapeutics Market

• 26.1. South America Addictions Therapeutics Market Overview
• 26.2. South America Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Addictions Therapeutics Market

• 27.1. Brazil Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Addictions Therapeutics Market

• 28.1. Middle East Addictions Therapeutics Market Overview
• 28.2. Middle East Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Addictions Therapeutics Market

• 29.1. Africa Addictions Therapeutics Market Overview
• 29.2. Africa Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Addictions Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Addictions Therapeutics Market Competitive Landscape
• 30.2. Addictions Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Addictions Therapeutics Market Other Major And Innovative Companies

• 31.1. Sun Pharmaceutical Industries Limited
• 31.2. Perrigo Company plc
• 31.3. Purdue Pharma L.P.
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Cipla Inc.
• 31.6. Hikma Pharmaceuticals plc
• 31.7. Amneal Pharmaceuticals Inc.
• 31.8. Mallinckrodt Plc
• 31.9. Alkermes plc.
• 31.10. Glenmark Pharmaceuticals Limited
• 31.11. Indivior plc.
• 31.12. Lannett Company Inc.
• 31.13. BioDelivery Sciences International Inc.
• 31.14. Insys Therapeutics Inc.
• 31.15. Camurus AB

32. Global Addictions Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Addictions Therapeutics Market

34. Recent Developments In The Addictions Therapeutics Market

35. Addictions Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Addictions Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Addictions Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Addictions Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer